10.1016/j.heares.2013.01.006 13 CevetteM
There's really no one-size-fits-all answer, which is why there's so much conflicting evidence
The review follows a shift in oversight to potentially increase access to these substances
When Results Plateau In community-reported reta+cagri protocols, plateaus are commonly reported at: Month 68 for users who hold retatrutide at 2 mg/week typically resolves by titrating retatrutide to 3 mg or holding while cagrilintide finishes ramping to 2.4 mg Month 12+ for users at the community ceiling (reta 4 mg + cagri 2.4 mg) no additional dose lever within the conservative community protocol
The choice of supplements has expanded over time and it is now possible to obtain highly-absorbable forms such as S-acetyl glutathione
Wang W, Pan YW, Zou J, Li T, Abel GM, Palmiter RD, et al